Tumor necrosis factor-α antagonist use and heart failure in elderly patients with rheumatoid arthritis

BACKGROUND: Clinical trials have shown that tumor necrosis factor-α antagonists (TNFAs) confer little benefit, and some may cause potential harm in advanced heart failure (HF). Although TNFAs had significant benefits in treating rheumatoid arthritis (RA), little is known whether the drugs pose an in...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Setoguchi, Soko, Schneeweiss, Sebastian, Avorn, Jerry, Katz, Jeffrey N., Weinblatt, Michael E., Levin, Raisa, Solomon, Daniel H.
Format: Artigo
Jezik:Inglês
Izdano: 2008
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3257055/
https://ncbi.nlm.nih.gov/pubmed/18657665
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ahj.2008.02.025
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items